Italy - English - HMA (Heads of Medicines Agencies)

merial sas - spot-on solution

Netherlands - English - HMA (Heads of Medicines Agencies)

merial sas - spot-on solution -

Slovenia - English - HMA (Heads of Medicines Agencies)

merial sas - spot-on solution -

United Kingdom - English - HMA (Heads of Medicines Agencies)

merial sas - spot-on solution -

European Union - English - EMA (European Medicines Agency)

mérial - bluetongue-virus serotype-2 antigen, bluetongue-virus serotype-4 antigen - bluetongue virus, inactivated viral vaccines, immunologicals for ovidae - sheep - active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.

European Union - English - EMA (European Medicines Agency)

merial - bluetongue-virus serotype-1 antigen - immunologicals - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.onset of immunity has been demonstrated three weeks after the primary vaccination course. the duration of immunity for cattle and sheep is one year after the primary vaccination course.

European Union - English - EMA (European Medicines Agency)

merial - bluetongue virus serotype 8 antigen - immunologicals for ovidae, immunologicals for bovidae - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.*(below the level of detection by the validated rt-pcr method at 3.14log10 rna copies/ml, indicating no infectious virus transmission).onset of immunity has been demonstrated 3 weeks after the primary vaccination course.the duration of immunity for cattle and sheep is 1 year after the primary vaccination course.the duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.

European Union - English - EMA (European Medicines Agency)

merial - fipronil, amitraz, (s)-methoprene - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of infestations in dogs by ticks (ixodes ricinus, dermacentor reticulatus, rhipicephalus sanguineus, ixodes scapularis, dermacentor variabilis, haemaphysalis elliptica, haemaphysalis longicornis, amblyomma americanum and amblyomma maculatum) and fleas (ctenocephalides felis and ctenocephalides canis). treatment of infestations by chewing lice (trichodectes canis). prevention of environmental flea contamination by inhibiting the development of all flea immature stages. the product can be used as part of a treatment strategy for the control of flea-allergy dermatitis. elimination of fleas and ticks within 24 hours. one treatment prevents further infestations for five weeks by ticks and for up to five weeks by fleas.the treatment indirectly reduces the risk of transmission of tick-borne diseases (canine babesiosis, monocytic ehrlichiosis, granulocytic anaplasmosis and borreliosis) from infected ticks for four weeks.

European Union - English - EMA (European Medicines Agency)

merial - inactivated ibr virus - immunologicals for bovidae - cattle - active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion., the onset of immunity is 14 days and the duration of immunity is 6 months.,

European Union - English - EMA (European Medicines Agency)

merial - live attenuated muscovy duck parvovirus - immunologicals for aves, duck parvovirus, live viral vaccines - ducks - active immunisation of ducks to prevent mortality1 and to reduce weight loss and lesions of duck parvovirosis and derzsy's disease.1in absence of maternally derived antibodies.